Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Wiley LA, Anfinson KR, Cranston CM, Kaalberg EE, Collins MM, Mullins RF, Stone EM, Tucker BA.

Curr Protoc Stem Cell Biol. 2017 Aug 14;42:4A.12.1-4A.12.14. doi: 10.1002/cpsc.30.

2.

Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.

Rodríguez-Pizà I, Richaud-Patin Y, Vassena R, González F, Barrero MJ, Veiga A, Raya A, Izpisúa Belmonte JC.

Stem Cells. 2010 Jan;28(1):36-44. doi: 10.1002/stem.248.

3.

cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.

Wiley LA, Burnight ER, DeLuca AP, Anfinson KR, Cranston CM, Kaalberg EE, Penticoff JA, Affatigato LM, Mullins RF, Stone EM, Tucker BA.

Sci Rep. 2016 Jul 29;6:30742. doi: 10.1038/srep30742.

4.

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.

Baghbaderani BA, Tian X, Neo BH, Burkall A, Dimezzo T, Sierra G, Zeng X, Warren K, Kovarcik DP, Fellner T, Rao MS.

Stem Cell Reports. 2015 Oct 13;5(4):647-59. doi: 10.1016/j.stemcr.2015.08.015. Epub 2015 Sep 24.

5.

Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.

Tucker BA, Anfinson KR, Mullins RF, Stone EM, Young MJ.

Stem Cells Transl Med. 2013 Jan;2(1):16-24. doi: 10.5966/sctm.2012-0040. Epub 2012 Dec 27.

6.

Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.

Lukovic D, Bolinches-Amorós A, Artero-Castro A, Pascual B, Carballo M, Hernan I, Erceg S.

Stem Cell Res. 2017 May;21:23-25. doi: 10.1016/j.scr.2017.03.007. Epub 2017 Mar 15.

7.

A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.

Lu HF, Chai C, Lim TC, Leong MF, Lim JK, Gao S, Lim KL, Wan AC.

Biomaterials. 2014 Mar;35(9):2816-26. doi: 10.1016/j.biomaterials.2013.12.050. Epub 2014 Jan 9.

PMID:
24411336
8.

Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.

Lieu PT.

Methods Mol Biol. 2015;1330:47-54. doi: 10.1007/978-1-4939-2848-4_5.

PMID:
26621588
9.

Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.

Wang J, Hao J, Bai D, Gu Q, Han W, Wang L, Tan Y, Li X, Xue K, Han P, Liu Z, Jia Y, Wu J, Liu L, Wang L, Li W, Liu Z, Zhou Q.

Stem Cell Res Ther. 2015 Nov 12;6:223. doi: 10.1186/s13287-015-0206-y.

10.

cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.

Parr AM, Walsh PJ, Truong V, Dutton JR.

Methods Mol Biol. 2016;1357:221-9. doi: 10.1007/7651_2015_243.

PMID:
25863788
11.

Fibroblast-like cells as an effective feeder for the cultivation and derivation of new lines of human induced pluripotent stem cells.

Novosadova EV, Manuilova ES, Arsenyeva EL, Grivennikov IA, Myasoedov NF.

Dokl Biochem Biophys. 2016 Sep;470(1):353-356. Epub 2016 Nov 6.

PMID:
27817014
12.

Derivation of Neural Stem Cells from Mouse Induced Pluripotent Stem Cells.

Karanfil I, Bagci-Onder T.

Methods Mol Biol. 2016;1357:329-38. doi: 10.1007/7651_2015_227.

PMID:
25863785
13.

Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.

Zhou H, Martinez H, Sun B, Li A, Zimmer M, Katsanis N, Davis EE, Kurtzberg J, Lipnick S, Noggle S, Rao M, Chang S.

Stem Cell Rev. 2015 Aug;11(4):652-65. doi: 10.1007/s12015-015-9586-8.

14.

Footprint- and xeno-free human iPSCs derived from urine cells using extracellular matrix-based culture conditions.

Lee KI, Kim HT, Hwang DY.

Biomaterials. 2014 Sep;35(29):8330-8. doi: 10.1016/j.biomaterials.2014.05.059. Epub 2014 Jun 30.

PMID:
24994040
15.

Human-induced pluripotent stem cells produced under xeno-free conditions.

Ross PJ, Suhr ST, Rodriguez RM, Chang EA, Wang K, Siripattarapravat K, Ko T, Cibelli JB.

Stem Cells Dev. 2010 Aug;19(8):1221-9. doi: 10.1089/scd.2009.0459.

PMID:
20030562
16.

Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.

Sa-Ngiamsuntorn K, Hongeng S, Wongkajornsilp A.

Curr Protoc Stem Cell Biol. 2017 Aug 14;42:4A.13.1-4A.13.34. doi: 10.1002/cpsc.35.

PMID:
28806853
17.

Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.

Jin ZB, Okamoto S, Xiang P, Takahashi M.

Stem Cells Transl Med. 2012 Jun;1(6):503-9. doi: 10.5966/sctm.2012-0005. Epub 2012 Jun 1.

18.

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.

Awe JP, Lee PC, Ramathal C, Vega-Crespo A, Durruthy-Durruthy J, Cooper A, Karumbayaram S, Lowry WE, Clark AT, Zack JA, Sebastiano V, Kohn DB, Pyle AD, Martin MG, Lipshutz GS, Phelps PE, Pera RA, Byrne JA.

Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.

19.

Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.

Durruthy JD, Sebastiano V.

Methods Mol Biol. 2015;1283:31-42. doi: 10.1007/7651_2014_124.

PMID:
25304205
20.

Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.

Trevisan M, Desole G, Costanzi G, Lavezzo E, Palù G, Barzon L.

Int J Mol Sci. 2017 Jan 20;18(1). pii: E206. doi: 10.3390/ijms18010206.

Supplemental Content

Support Center